Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.
Jeffrey A. Gottlieb(The University of Texas MD Anderson Cancer Center), Thomas E. Moon(Virginia Commonwealth University Medical Center), Robert S. Benjamin(The University of Texas MD Anderson Cancer Center), Laurence H. Baker(Memorial Sloan Kettering Cancer Center), Saul E. Rivkin(University of Puget Sound), Charles A. Coltman(Wilford Hall Ambulatory Surgical Center), Joseph M. Quagliana, G. R. Blumenschein, J. G. Sinkovics, Patricia Sullivan, Robert M. OʼBryan, S P Balcerzak, John H. Saiki(University of New Mexico), Tate Thigpen, M. A. Burgess, G. P. Bodey(The University of Texas MD Anderson Cancer Center), Barth Hoogstraten, V. Rodriguez, R Bottomley
Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)
February 1, 1976
Cited by 141
Related Papers
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|733
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636
Prostaglandin-Producing Suppressor Cells in Hodgkin's Disease
|New England Journal of Medicine|1977|545
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
|The Journal of Infectious Diseases|1985|408